Track the Medivir Aktiebolag share price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Medivir Aktiebolag has published 1 insider filings. Market capitalisation: €1bn. The latest transaction was filed on 5 December 2025 (Purchase). Among the most active insiders: Fredrik Öberg. The full history is openly available.
Analysts rate Medivir Aktiebolag Buy (bullish), based on 3 analysts. Average price target: SEK 4.98.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration